Immune Response Biopharma entered the industry of Business Consultants in 2010 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code , which describes it as a Business Consultants. For further clarification, the SIC classifies this business under the code and described it as a Business Consultants. The business provides service to the B2B market.
To acquire more information, please contact David Buswell by calling (917) 275-7931 during business hours. You can also write to the business’ Single Location at 244 5th Avenue Suite 1727, New York City, New York NY 10001. You can also visit the company’s website at immuneresponsebiopharma.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Immune Response Biopharma |
| Representative: | David Buswell |
| Place of Business: | 244 5th Avenue Suite 1727, New York City, NY 10001 |
| Contact Number: | (917) 275-7931 |
| Website: | immuneresponsebiopharma.com |
| Type of Service: | Business Consultants |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2010 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Immune Response Biopharma is a company operating from New York, New York providing professional Business Consultants and relevant B2B variables. It was founded in 2010 and registered with the SIC code as Business Consultants, and with the NAICS code as Business Consultants.
With a current employee count of 1 to 4, Immune Response Biopharma has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative David Buswell at (917) 275-7931 for related queries, or to locate its Single Location using the coordinates 40.74406,-73.98774.
The Single Location can also be found at the street address 244 5th Avenue Suite 1727 in New York City, New York 10001 and can be engaged online through the company website at immuneresponsebiopharma.com, the company Twitter , and Facebook page .